MedTrace Logo

Radiofrequency and Chemical Neurolysis of Thoracic Splanchnic Nerve for Abdominal Cancer Pain

NCT03063112 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2017-02-28

No results posted yet for this study

Summary

The study compares between the efficacy, safety and impact on the quality of life of radiofrequency thermocoagulation and chemical neurolysis of bilateral thoracic splanchnic nerves in the management of refractory pain which developed in patients suffering from upper abdominal cancer.

Conditions

  • Abdominal Cancer

Interventions

DEVICE

Radiofrequency generator device

sympathetic blockade or ablation of thoracic splanchnic nerves

DRUG

Lidocaine

sympathetic blockade or ablation of thoracic splanchnic nerves

DEVICE

C arm fluoroscopic device

sympathetic blockade or ablation of thoracic splanchnic nerves

DRUG

Ethyl alcohol

sympathetic blockade or ablation of thoracic splanchnic nerves

Sponsors & Collaborators

  • South Egypt Cancer Institute

    lead OTHER

Principal Investigators

  • Samy A Erfan, Professor · Head of the department

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2017-04-10
Completion
2017-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063112 on ClinicalTrials.gov